EX-25.1 12 d456916dex251.htm EX25.1 EX25.1

Exhibit 25.1

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM T-1

 

 

STATEMENT OF ELIGIBILITY

UNDER THE TRUST INDENTURE ACT OF 1939 OF A

CORPORATION DESIGNATED TO ACT AS TRUSTEE

 

¨ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2)

 

 

THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.

(Exact name of trustee as specified in its charter)

 

 

 

  95-3571558

(State of incorporation

if not a U.S. national bank)

 

(I.R.S. employer

identification no.)

400 South Hope Street

Suite 400

Los Angeles, California

  90071
(Address of principal executive offices)   (Zip code)

Evelyn T. Furukawa

The Bank of New York Mellon Trust Company, N.A.

400 South Hope Street, Suite 400

Los Angeles, CA 90071

(Name, address and telephone number of agent for service)

 

 

ALERE INC.

(Exact name of obligor as specified in its charter)

 

 

 

Delaware   04-3565120
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. employer
identification no.)

51 Sawyer Road, Suite 200

Waltham, Massachusetts

  02453
(Address of principal executive offices)   (Zip code)

 

 

7.250% Senior Notes due 2018

(Title of the Indenture Securities)

 

 

 


TABLE OF ADDITIONAL REGISTRANTS

The direct and indirect wholly owned domestic subsidiaries of Alere Inc. listed in the table below are expected to guarantee the debt securities issued pursuant to this registration statement. The address, including zip code, and telephone number, including area code, of each of the co-registrants is 51 Sawyer Road, Suite 200, Waltham, Massachusetts, 02453, (781) 647-3900.

 

Exact Name of Additional Registrant as

Specified in its Charter

   State or Other

Jurisdiction of

Incorporation or

Organization

      

 

 

I.R.S. Employer

Identification

Number

  

  

  

Alere Accountable Care Solutions, LLC

   Delaware        45-4003108  

Alere Health, LLC

   Delaware        26-2564744  

Alere Health Improvement Company

   Delaware        22-3493126  

Alere Healthcare of Illinois, Inc.

   Georgia        58-2068880  

Alere Home Monitoring, Inc.

   Delaware        20-0391730  

Alere Informatics, Inc.

   Virginia        54-1708417  

Alere International Holding Corp.

   Delaware        20-0963463  

Alere NewCo, Inc.

   Delaware        27-2104833  

Alere NewCo II, Inc.

   Delaware        27-2104868  

Alere North America, Inc.

   Delaware        26-1444559  

Alere of New York, Inc.

   New York        58-1873062  

Alere San Diego, Inc.

   Delaware        33-0288606  

Alere Scarborough, Inc.

   Delaware        20-2507302  

Alere Toxicology Services, Inc.

   Louisiana        72-0846066  

Alere US Holdings, LLC

   Delaware        26-0349667  

Alere Wellbeing, Inc.

   Delaware        20-0231080  

Alere Wellology, Inc.

   Delaware        54-1776557  

Alere Women’s and Children’s Health, LLC

   Delaware        58-2205984  

Ameditech Inc.

   California        33-0859551  

ATS Laboratories, Inc.

   Delaware        45-3168051  

Avee Laboratories, Inc.

   Florida        26-3693303  

Binax, Inc.

   Delaware        36-4668096  

Biosite Incorporated

   Delaware        27-2104785  

eScreen, Inc.

   Delaware        95-4810460  

First Check Diagnostics Corp.

   Delaware        20-8329751  

First Check Ecom, Inc.

   Massachusetts        33-1026518  

Global Analytical Development LLC

   Florida        27-2047994  

Innovacon, Inc.

   Delaware        20-1100264  

Instant Technologies, Inc.

   Virginia        54-1837621  

Inverness Medical, LLC

   Delaware        26-0392649  

Ionian Technologies, Inc.

   Delaware        91-2089242  

IVC Industries, Inc.

   Delaware        22-1567481  

Laboratory Specialists of America, Inc.

   Oklahoma        73-1451065  

Pembrooke Occupational Health, Inc.

   Virginia        54-1522061  

Quality Assured Services, Inc.

   Florida        59-3437644  

Redwood Toxicology Laboratory, Inc.

   California        68-0332937  

RMD Networks, Inc.

   Delaware        84-1581993  

RTL Holdings, Inc.

   Delaware        20-4371685  

Screen Tox, Inc.

   Florida        26-3247189  

Selfcare Technology, Inc.

   Delaware        04-3383533  

Standing Stone, Inc.

   Delaware        06-1575899  

ZyCare, Inc.

   North
Carolina
       56-1398496  

 


1. General information. Furnish the following information as to the trustee:

 

  (a) Name and address of each examining or supervising authority to which it is subject.

 

Name

  

Address

Comptroller of the Currency

United States Department of the Treasury

   Washington, D.C. 20219

Federal Reserve Bank

   San Francisco, California 94105

Federal Deposit Insurance Corporation

   Washington, D.C. 20429

 

  (b) Whether it is authorized to exercise corporate trust powers.

Yes.

 

2. Affiliations with Obligor.

If the obligor is an affiliate of the trustee, describe each such affiliation.

None.

 

3-15.  Not applicable.

 

16. List of Exhibits.

Exhibits identified in parentheses below, on file with the Commission, are incorporated herein by reference as an exhibit hereto, pursuant to Rule 7a-29 under the Trust Indenture Act of 1939 (the “Act”) and 17 C.F.R. 229.10(d).


1. A copy of the articles of association of The Bank of New York Mellon Trust Company, N.A. (Exhibit 1 to Form T-1 filed as Exhibit 25.1 to the Registration Statement on Form S-3 File No. 333-121948 and Exhibit 1 to Form T-1 filed as Exhibit 25.1 to the Registration Statement on Form S-3 No. 333-152875).

 

2. A copy of certificate of authority of the trustee to commence business. (Exhibit 2 to Form T-1 filed as Exhibit 25.1 to the Registration Statement on Form S-3 File No. 333-121948).

 

3. A copy of the authorization of the trustee to exercise corporate trust powers. (Exhibit 3 to Form T-1 filed as Exhibit 25.1 to the Registration Statement on Form S-3 File No. 333-152875).

 

4. A copy of the existing by-laws of the trustee. (Exhibit 4 to Form T-1 filed as Exhibit 25.1 to the Registration Statement on Form S-3 File No. 333-152875).

 

6. The consent of the trustee required by Section 321(b) of the Act.

 

7. A copy of the latest report of condition of the trustee published pursuant to law or to the requirements of its supervising or examining authority.


SIGNATURE

Pursuant to the requirements of the Act, the trustee, The Bank of New York Mellon Trust Company, N.A., a banking association organized and existing under the laws of the United States of America, has duly caused this statement of eligibility to be signed on its behalf by the undersigned, thereunto duly authorized, all in The City of Chicago, and State of Illinois, on the 5th day of April, 2013.

 

THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
By:   /s/ Linda Garcia
  Name:   Linda Garcia
  Title:     Vice President


EXHIBIT 6

CONSENT OF THE TRUSTEE

Pursuant to the requirements of Section 321 (b) of the Trust Indenture Act of 1939, and in connection with the proposed issue of Alere Inc.’s senior notes, The Bank of New York Mellon Trust Company, N.A. hereby consents that reports of examinations by Federal, State, Territorial or District authorities may be furnished by such authorities to the Securities and Exchange Commission upon request therefore.

 

THE BANK OF NEW YORK MELLON

TRUST COMPANY, N.A.

By:   /s/ Linda Garcia
 

Linda Garcia

Vice President

Chicago, Illinois

April 5, 2013


EXHIBIT 7

Consolidated Report of Condition of

THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.

of 400 South Hope Street, Suite 400, Los Angeles, CA 90071

At the close of business December 31, 2012, published in accordance with Federal regulatory authority instructions.

 

     Dollar Amounts
in Thousands
 

ASSETS

  

Cash and balances due from depository institutions:

  

Noninterest-bearing balances and currency and coin

     1,455   

Interest-bearing balances

     1,301   

Securities:

  

Held-to-maturity securities

     0   

Available-for-sale securities

     660,687   

Federal funds sold and securities purchased under agreements to resell:

  

Federal funds sold

     73,000   

Securities purchased under agreements to resell

     0   

Loans and lease financing receivables:

  

Loans and leases held for sale

     0   

Loans and leases, net of unearned income

     0   

LESS: Allowance for loan and lease losses

     0   

Loans and leases, net of unearned income and allowance

     0   

Trading assets

     0   

Premises and fixed assets (including capitalized leases)

     5,887   

Other real estate owned

     0   

Investments in unconsolidated subsidiaries and associated companies

     0   

Direct and indirect investments in real estate ventures

     0   

Intangible assets:

  

Goodwill

     856,313   

Other intangible assets

     159,149   

Other assets

     150,314   
  

 

 

 

Total assets

   $ 1,908,106   
  

 

 

 

 

1


LIABILITIES

 

Deposits:

 

In domestic offices

    498   

Noninterest-bearing

    498   

Interest-bearing

    0   

Not applicable

 

Federal funds purchased and securities sold under agreements to repurchase:

 

Federal funds purchased

    0   

Securities sold under agreements to repurchase

    0   

Trading liabilities

    0   

Other borrowed money:

 

(includes mortgage indebtedness and obligations under capitalized leases)

    0   

Not applicable

 

Not applicable

 

Subordinated notes and debentures

    0   

Other liabilities

    236,096   

Total liabilities

    236,594   

Not applicable

 

EQUITY CAPITAL

 

Perpetual preferred stock and related surplus

    0   

Common stock

    1,000   

Surplus (exclude all surplus related to preferred stock)

    1,121,520   

Not available

 

Retained earnings

    544,518   

Accumulated other comprehensive income

    4,474   

Other equity capital components

    0   

Not available

 

Total bank equity capital

    1,671,512   

Noncontrolling (minority) interests in consolidated subsidiaries

    0   

Total equity capital

    1,671,512   
 

 

 

 

Total liabilities and equity capital

    1,908,106   
 

 

 

 

I, Cherisse Waligura, CFO of the above-named bank do hereby declare that the Reports of Condition and Income (including the supporting schedules) for this report date have been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and are true to the best of my knowledge and belief.

Cherisse Waligura            )             CFO

We, the undersigned directors (trustees), attest to the correctness of the Report of Condition (including the supporting schedules) for this report date and declare that it has been examined by us and to the best of our knowledge and belief has been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and is true and correct.

 

Troy Kilpatrick, President

  

)

 

Frank P. Sulzberger, MD

  

)

 

Directors (Trustees)

William D. Lindelof, MD

  

)

 

 

2